Revibe Technologies, Developer of a Wearable Digital Therapeutic for ADHD, announces that Dr. Michael Ackermann has joined the Board of Directors
March 23, 2022 07:00 ET | Revibe Technologies
WAKE FOREST, N.C., March 23, 2022 (GLOBE NEWSWIRE) -- Revibe Technologies announced today that Dr. Michael Ackermann was elected to the Company's Board of Directors effective March 15, 2022. Dr....
Revibe Technologies Announces Clinical Development Updates for its Investigational FokusRx Prescription Digital Therapy for the Treatment of ADHD
February 08, 2022 15:21 ET | Revibe Technologies
– FokusRx™ feasibility study demonstrates positive results – – Company plans to initiate Phase 3 trial with FokusRx in ADHD in the second half of 2022 – Wake Forest, North Carolina, Feb. 08,...